Cristina Bertolotto, MD

Department of Pediatrics, University of California, Los Angeles

Dr. Christina Bertolotto is a bilingual biomedical executive senior manager with strong operational expertise in the field of translational research and technology transfer. An extensive background in medicine and medical research, coupled with real-world managing experience, have built the skills needed to scout, identify, develop and assess the market demand and viability of inventions.

Dr. Bertolotto has a keen understanding of the challenges involved in bringing together solid scientific standards and promising business opportunities. Excels at identifying high-priority opportunity areas and developing out-of-the-box solutions based on a strong research background in neurosciences, stem cells, in-vitro and in-vivo experiments, genetics, endocrinology, metabolic diseases, inflammation, fibrosis and infectious diseases. Outstanding personal experience at the academia.

An extensive network of contacts at UCLA, St. John’s, City of Hope, Cedars Sinai Medical Center and research hubs around the world, including private and governmental institutions in Latin America and Eastern Europe.

The Orthobiologic Institute (TOBI) was established by Dr. Steven Sampson to share best practices in the cutting-edge field of Platelet Rich Plasma (PRP) and regenerative medicine therapies with physicians around the world.

The Orthobiologic Institute (TOBI) was established by Dr. Steven Sampson to share best practices in the cutting-edge field of orthobiologics and regenerative medicine therapies with physicians around the world.